Bridges Investment Management Inc. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 173,388 shares of the medical equipment provider's stock after acquiring an additional 1,242 shares during the period. Intuitive Surgical accounts for 1.3% of Bridges Investment Management Inc.'s investment portfolio, making the stock its 23rd biggest holding. Bridges Investment Management Inc.'s holdings in Intuitive Surgical were worth $94,221,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Invesco Ltd. raised its position in shares of Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider's stock valued at $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Northern Trust Corp raised its position in shares of Intuitive Surgical by 0.3% during the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock valued at $1,798,465,000 after buying an additional 11,988 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Nuveen LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at about $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company's stock.
Intuitive Surgical Stock Down 0.2%
NASDAQ:ISRG opened at $435.61 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $156.16 billion, a PE ratio of 60.75, a price-to-earnings-growth ratio of 4.58 and a beta of 1.61. The firm has a 50-day moving average price of $456.15 and a 200 day moving average price of $496.60.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.78 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on ISRG shares. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Mizuho cut their price objective on shares of Intuitive Surgical from $570.00 to $520.00 and set a "neutral" rating for the company in a research report on Tuesday. Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $582.14.
Get Our Latest Stock Analysis on Intuitive Surgical
Insiders Place Their Bets
In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amy L. Ladd sold 335 shares of the company's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by insiders.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.